Bank of New York Mellon »

Halozyme Therapeutics shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2024-03-31 $533k 600k 0.89
2023-12-31 $518k 600k 0.86
2023-03-31 $271k 320k 0.85
2022-12-31 $584k 600k 0.97
2022-09-30 $682k 800k 0.85
2022-06-30 $712k 800k 0.89
2022-03-31 $702k 800k 0.88